SCHEMBL14905656

SCHEMBL14905656

CCOC(=O)[C@]12C[C@@H]1C=CCCCCC[C@H](N1CCCCC1)C(=O)N1C[C@H](Oc3cc(-c4ccccc4)nc4cc(OC)ccc34)C[C@H]1C(=O)N2

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.56
▸ ADRB3 P13945 1/20 0.48
▸ ADRA2B P18089 1/20 0.48
▸ ADRA2C P18825 1/20 0.48
▸ CTSS P25774 1/20 0.38
▸ CYP3A4 P08684 2/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ CALCRL Q16602 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13047541 1.00 CTSB (0.56) CTSBADRB3ADRA2BADRA2CCTSS
SCHEMBL13047659 1.00 CTSB (0.56) CTSBADRB3ADRA2BADRA2CCTSS
SCHEMBL14905657 1.00 CTSB (0.56) CTSBADRB3ADRA2BADRA2CCTSS
SCHEMBL14905673 1.00 CTSB (0.56) CTSBADRB3ADRA2BADRA2CCTSS
SCHEMBL13047663 1.00 CTSB (0.56) CTSBADRB3ADRA2BADRA2CCTSS
SCHEMBL14905668 0.93 CTSB (0.60) CTSBADRB3ADRA2BADRA2CCTSS
SCHEMBL13047666 0.93 CTSB (0.60) CTSBADRB3ADRA2BADRA2CCTSS
SCHEMBL13047553 0.93 CTSB (0.60) CTSBADRB3ADRA2BADRA2CCTSS
SCHEMBL1462139 0.91 CTSB (0.54) CTSBADRB3ADRA2BADRA2CCTSS
SCHEMBL1462130 0.91 CTSB (0.54) CTSBADRB3ADRA2BADRA2CCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435984-B2 Tertiary amine substituted peptides useful as inhibitors of HCV replication ACHILLION PHARMACEUTICALS, INC. (US) 2013-05-07 — — US claimed
Send feedback